Home 
HOME Bratislava Medical Journal 2020 Bratislava Medical Journal Vol.121, No.10, p.722–726,2020
HOME Bratislava Medical Journal 2020 Bratislava Medical Journal Vol.121, No.10, p.722–726,2020
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.121, No.10, p.722–726,2020 |
||
| Title: Simvastatin in an experimental spinal cord injury model: a histopathological and biochemical evidence based study | ||
| Author: T. Tascioglu, M. Karatay, Y. Erdem, A. Tekiner, H. Celik, O. Sahin, I. Sertbas, M. A. Bayar | ||
| Abstract: AIM: In this study we tried to determine the possible neuroprotective effects of simvastatin in a rat model of Spinal Cord Injury (SCI) with the help of biochemical and histopathological tests. METHODS: Rats were divided into 5 groups:1) SCI control, 2) Sham operated, 3) SCI with 10 mg/kg intraperitoneal simvastatin, 4) SCI with 10 mg/kg oral simvastatin, 5) SCI with 10 mg/kg subcutaneous simvastatin. After the treatment period, all rats were sacrificed; their blood and spinal cord samples were taken for biochemical and histopathological assessment. RESULTS: When the groups were compared in terms of oedema and inflammation status, the scores of groups receiving simvastatin were better than the control and sham groups (p = 0.001 and p = 0.038 respectively). When the 3 treatment groups (oral, intraperitoneal and subcutaneous simvastatin groups) were compared with each other in terms of inflammation, haemorrhage and oedema, there were no significant differences between groups (p = 0.112, p = 0.797 and p = 0.188, respectively). NSE and S100B levels were significantly lower in the treatment groups compared to the sham group (p = 0.039 and p = 0.004 respectively). CONCLUSION: According to our biochemical and histopathological findings, simvastatin 10 mg/kg has a positive impact in the spinal cord injury model in rats, regardless of route of application (Tab. 1, Fig. 5, Ref. 26). |
||
| Keywords: spinal cord injury, simvastatin, neuroprotective effect | ||
| Published online: 20-Sep-2020 | ||
| Year: 2020, Volume: 121, Issue: 10 | Page From: 722, Page To: 726 | |
| doi:10.4149/BLL_2020_118 |
||
|
|
 download file |
|